Patented Substrates:
Glycosynth is developing an exciting range of new chromogenic substrates in conjunction with Prof John Perry, Microbiology Department, Freeman Hospital, Newcastle upon Tyne, England. These products show a number of distinct advantages over conventional substrates under certain circumstances, and are sure to find important applications.
Product Licences
Glycosynth welcomes enquiries for the use of its patented technology. Exclusive licensing arrangements can be considered.
This section is further divided into the following sub-sections ...
| > | Chromogenic Catechol and Dihydroxyflavone substrates |
| > | Chromogenic β-D-Ribofuranoside substrates |
 |
 |
 |
 |
